Market Cap (In KRW)
512.67 Billion
Revenue (In KRW)
68.86 Billion
Net Income (In KRW)
48.36 Billion
Avg. Volume
110.25 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 15000.0-29750.0
- PE
- -
- EPS
- -
- Beta Value
- 0.42
- ISIN
- KR7290650001
- CUSIP
- -
- CIK
- -
- Shares
- 22684900.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Mr. Chul Lee Whan
- Employee Count
- -
- Website
- http://www.lncbio.co.kr
- Ipo Date
- 2018-11-01
- Details
- L&C BIO Co., Ltd. operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam, South Korea.
More Stocks
-
OCAX
-
FNRC1st NRG Corp.
FNRC
-
002976
-
GULFOILLUBGulf Oil Lubricants India Limited
GULFOILLUB
-
AGYTFAllergy Therapeutics plc
AGYTF
-
CLN
-
ENTRINTEnterprise International Limited
ENTRINT
-
JETAIRWAYSJet Airways (India) Limited
JETAIRWAYS